Movano Stock Quote MOVE - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Movano Inc (MOVE) Quote

Movano Inc (MOVE)

3.44

0.00

(0.00%)

Closed November 25 4:00PM

Delayed by 15 minutes

3.44

0.00

(0.00%)

After Hours: 5:04PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

3.44

Bid

2.54

Ask

4.00

Volume

-

0.00 Day's Range 0.00

2.80 52 Week Range 14.70

Market Cap

Previous Close

3.44

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

138,379

Shares Outstanding

6,600,000

Dividend Yield

-

PE Ratio

-0.78

Earnings Per Share (EPS)

-4.44

Revenue

-

Net Profit

-29.28M

Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequenc... Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors. Show more

Sector

Electromedical Apparatus

Industry

Electromedical Apparatus

Website

www.movanohealth.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Movano Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker MOVE. The last closing price for Movano was $3.44. Over the last year, Movano shares have traded in a share price range of $ 2.80 to $ 14.70.

Movano currently has 6,600,000 shares outstanding. The market capitalization of Movano is $22.70 million. Movano has a price to earnings ratio (PE ratio) of -0.78.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Movano Health Reports Q3 2024 Financial Results and Provides Business Update PR Newswire PLEASANTON, Calif., Nov. 14, 2024 Highlights successful Evie Ring back-in-stock execution Updates status...

Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device

Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device PR Newswire PLEASANTON, Calif., Nov. 7, 2024 New hardware boasts significant improvements to reduce...

Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024

Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024 PR Newswire PLEASANTON, Calif., Nov. 6, 2024 Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON...

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED PR Newswire PLEASANTON, Calif., Nov. 4, 2024 Company remains optimistic on the potential for this pioneering...

Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split PR Newswire PLEASANTON, Calif., Oct. 31, 2024 Company Communicating with Securities...

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio PR Newswire PLEASANTON, Calif., Oct. 30, 2024 Collaboration Will Expand Awareness of Movano's Female First...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.29	9.20634920635	3.15	3.4929	2.8	13893	3.15960162	CS
4	-0.985	-22.2598870056	4.425	4.61	2.8	120099	3.86951738	CS
12	-1.294	-27.3341782847	4.734	6.03	2.8	138379	4.5813999	CS
26	-3.31	-49.037037037	6.75	6.9075	2.8	196033	5.18947706	CS
52	-10.8655	-75.953304673	14.3055	14.7	2.8	178459	6.57329058	CS
156	-52.66	-93.8680926916	56.1	61.65	2.8	89902	13.18989509	CS
260	-310.81	-98.9053301512	314.25	314.25	2.8	73007	19.601937	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	$ 8.26 (89.02%)	2.03M
XCURExicure Inc	$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	$ 8.24 (18.05%)	107.91M

Monroe1

Monroe1 5 days ago

https://eviering.com/products/evie-ring?_kx=rqRxv3MT2Gd6dvbqVRW0W---ss2aQ4O026nbc2LnAJ8.XWzX8R
Ho HO Ho... Merry Christmas

"Made with scratch resistant Liquid Metal"

Almosthere

Almosthere 7 days ago

$3.10
Not a positive response to the ER. Once again the reverse is hurting without news to back it up.

Almosthere

Almosthere 7 days ago

$3.10
Not a positive response to the ER. Once again the reverse is hurting without news to back it up.

chipboarder

chipboarder 1 week ago

ER is about what I expected…perhaps a bit light on units sold but no real surprises. I’m still positive especially since there are only 6 million shares outstanding after the RS.

With 6 million shares, the possibility of $1 a share earnings only requires sales of something like $25 million or 100k units. This looks like a big number but it’s only 8K a month. Approval is key to achieving these sorts of volume.

Funding will rear its head in a year or so without FDA push so dilution could be on the horizon.

Almosthere

Almosthere 4 weeks ago

These RS rarely turn out good. I am surprised they did this with out announcing something to keep the share price up.

Almosthere

Almosthere 4 weeks ago

These RS rarely turn out good. I am surprised they did this with out announcing something to keep the share price up.

Monroe1

Monroe1 1 month ago

RS coming. In the news.

chipboarder

chipboarder 3 months ago

No sign of a pulse…NB was right…it’s dead Jim!

chipboarder

chipboarder 3 months ago

Over on the other message board (LQMT) I’ve been trying to guess the identity of the “Tier 1 Medical Device Supplier” who participated in the last round of funding to the tune of $3 million. This is not a huge amount of money and only amounted to about 10% of the funds raised. I used the “top 10” medical device list and planned to concentrate on companies with some sort of a Boston (New England) connection since Movano Health has a joint program with MIT.

My GUESS is Phillips Healthcare (a sister division of Phillips Electronics the supplier of the RF technology). The next question is whether taking a financial position is the first step in a possible acquisition move…..ALL SPECULTION.

chipboarder

chipboarder 3 months ago

Maybe we can pump some life in this board……Dexcom announced a continuous glucose monitoring device today….It’s a patch that is applied to the back of the arm and it has a probe that penetrates the skin. I read a review on the CNBC website where the person testing the unit had bleeding on the first try and had to repeat the process on the other arm with a fresh device. Not exactly a perfect experience. The cost is $99/month ($89 by subscription) and is covered by most insurance plans. It communicates with a phone via Bluetooth with 15 minute updates. ..Normally needs replacement every 15 days.

Disadvantages….penetrates the skin to get a reading…subscription cost is huge …even though covered by insurance. Skillful marketing should circumvent this threat.

chipboarder

chipboarder 3 months ago

I guess “spell-check” has decided that when someone types “whether” …they really mean “weather” at least 88% of the time so we will protect them from being mistaken.

chipboarder

chipboarder 3 months ago

What could be delaying the FDA approval process?

Staffing at the FDA….work load ….vacations….

The “newness” of the RF approach doesn’t fit the established protocol……they may be concerned about the technology’s longer term accuracy and weather will continue to perform.

Asking for “more data” which is code for “our approval process is behind schedule and we need to create slack in our schedule”.

We have absolutely no control over the timing….I’ll bet a nickel they have never been early.

FarmerJohn

FarmerJohn 4 months ago

Earnings next Wednesday, August 14
https://finance.yahoo.com/news/movano-health-report-second-quarter-130000259.html

Gumby525

Gumby525 4 months ago

Everyone just waiting on news. Hurry up and wait, then wait some more.

Nerd Beautiful

Nerd Beautiful 4 months ago

chipboarder

chipboarder 8 months ago

First…you need money for working capital to fund growth of the business, so raising capital is good even though it comes with dilution. Also good is $3.6 million raised came from “insiders” which assesses commitment (high). Investment from a medical device whale doesn’t hurt either.

Second …If the posters would research the sensor technology, they would learn that the competitors are using infrared transmission for the pulse oximeter and Movano uses radio frequency as its technical approach…and is unique. Apple ran afoul of Masimo patents and both are using IR.

Movano has more than 30 patents for the RF sensor technology makes them an acquisition target. I hope they get the opportunity to establish the enterprise before the offer comes,,,it would be a shame to sell out at $4 when it could be worth so much more down the road.

..

TheFinalCD

TheFinalCD 8 months ago

Private Placement 45,000,000 $0.53 45,000,000 $23,985,000 Benchmark Insiders 2024-4-2 17:01

stock1ace1

stock1ace1 8 months ago

They had a private Placement right after news ..

Movano Health Announces $24 Million Private Placement

TheFinalCD

TheFinalCD 8 months ago

what an ugly MOVE, GAP& TRAP personified

glad I missed this

Awl416

Awl416 8 months ago

Buy high sell low

thoand

thoand 8 months ago

Why the big MOVE after hours?

IVANj

IVANj 8 months ago

IVANj

IVANj 8 months ago

thoand

thoand 8 months ago

This message board is pretty good.

https://www.reddit.com/r/LQMT/s/OKyaczjzgS

derkampfer

derkampfer 8 months ago

Looks like everything on website, all finishes and sizes are “out of stock”

thoand

thoand 8 months ago

Not sure. LQMT investors are a little worried it might because of complaints about durability and scratches. Could be they sold out, but CEO publicly stated they had enough supplies on hand if there was increased demand. Some think something went wrong with the coating process. It’s anyone’s guess.

I forgot that people are hoping that Apple made them stop to buy them out and rebrand it Apple ring to compete with future Samsung ring.

derkampfer

derkampfer 8 months ago

I didn’t realize the Evie ring has not been available the last three weeks. Do you know why?

thoand

thoand 8 months ago

I only heard of MOVE by their involvement with LQMT. I am curious because LQMT had/has a relationship with Apple. With the lawsuit against Apple because of the oxygen sensor technology, it would seem that buying MOVE would be the perfect solution.

Apple also has patents for a ring device that seems similar to the Evie product. It is curious that the Evie ring has not been for sale for over 3 weeks and was wondering if Apple may have something to do with it.
.

derkampfer

derkampfer 8 months ago

It would seem to me once MOVE has FDA approval on their glucose monitoring chip that Apple would like to get their hands on it. Somehow. Not sure if that means MOVE keeps their women-centric Evie ring product line and sells Apple licensing rights to the chip or simply turns the whole company over and makes the Evie ring an Apple product offering, as they did with Beats by Dre and that $3B deal. Not the same since Beats was more about Apple buying the Dre name-culture-brand and in this case an acquisition by Apple of MOVE is for their tech. At which point medical grade glucose monitoring could then be incorporated into the AppleWatch and perhaps iPhone. That’s why we are invested. FDA approval of their glucose monitoring chip is a key event that they are working towards.

thoand

thoand 8 months ago

Any thoughts on the possibility that Apple buys MOVE to deal with outcome from Apple Watch lawsuit?

scott135

scott135 1 year ago

Back to back PRs. This one is starting to look good

Monksdream

Monksdream 1 year ago

MOVE new 52 week low

derkampfer

derkampfer 1 year ago

Evie ring coming in September 👍🏻

billionareboysclub

billionareboysclub 12 years ago

Move bought my last company Relocation.com. This company made MIllions of dollars in which Move.com will write off in Tax Dollares. This company will really MOVE once earnings are released. There going to report alot of gains. Better than EXPECTED IMO! Get in while its low.

Penny Roger$

Penny Roger$ 13 years ago

~ Thurs-Fri $MOVE ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $MOVE ~ Earnings expected on Friday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

http://stockcharts.com/h-sc/ui?s=MOVE&p=D&b=3&g=0&id=p88783918276&a=237480049

http://stockcharts.com/h-sc/ui?s=MOVE&p=W&b=3&g=0&id=p54550695994

~ Google Finance: http://www.google.com/finance?q=MOVE
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=MOVE#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=MOVE+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=MOVE
Finviz: http://finviz.com/quote.ashx?t=MOVE
~ BusyStock: http://busystock.com/i.php?s=MOVE&v=2

<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=MOVE >>>>>>

http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Penny Roger$

Penny Roger$ 13 years ago

Move, Inc. (Move) operates an online network of Websites for real estate search, finance, moving and home enthusiasts and provides a resource for consumers seeking the online information and connections they need regarding real estate. The Company’s consumer Websites are Move.com, REALTOR.com and Moving.com. It also provides lead management software for real estate agents and brokers through its Top Producer business. On the Company’s Websites it displays real estate property content, with over four million resale, new home and rental listings, as well as move-related information and tools. Move also has relationships with the real estate industry, including content agreements with approximately 900 multiple listing services (MLS) across the United States and partnerships with the National Association of REALTORS (NAR) and the National Association of Home Builders (NAHB). On June 22, 2009, it divested its interest in Welcome Wagon business. In July2011, the Company acquired SocialBios.

http://www.google.com/finance?q=MOVE

Delayed Upgrade Clock